GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...

On appointment, Dr Screaton will become a member of the GSK Board Science Committee and the Corporate Responsibility ...

GSK Plc is looking to further grow its cancer drug business, a senior executive said, after the drugmaker’s $1.15 billion ...

Once people don’t have justifiable access to medicine, the disease will stay longer with those people. Some will end up dying ...